Hint mode is switched on Switch off
For swift navigation between sections

LFB Biomedicaments
LEI 969500WARKTWUKB30C84

PDF download

Choose all Reset all
Download Cancel
Organization name
LFB Biomedicaments
Country name
France
Country of registration
France
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

LFB Biomedicaments was incorporated in 1994. The company is a French biopharmaceutical group that develops, manufactures, and markets plasma-derived medicinal products and recombinant proteins for the treatment of serious and often rare diseases. Its therapeutic focus includes immunology, haemostasis, and intensive care. The company is a subsidiary of the LFB Group, which is owned by the French State.

Awards

Documentation

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    969500WARKTWUKB30C84
  • NACE
    *** ***
  • NAICS
    *** ***
  • SIREN
    491371167
Registration is required to get access.